Xtant Medical Holdings, Inc. (XTNT)
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $133.9M
- Net income
- $5.0M
- Total assets
- $94.1M
- Market cap
- $63.9M
- Gross margin
- 62.9%
- Operating margin
- 5.4%
- Net margin
- 3.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $133.9M
- Cost of revenue
- $49.7M
- Gross profit
- $84.3M
- Operating expenses
- $77.0M
- Operating income
- $7.3M
- Income tax
- $2.0M
- Net income
- $5.0M
- EPS (basic)
- $0.04
- EPS (diluted)
- $0.03
Balance sheet
- Total assets
- $94.1M
- Current assets
- $78.2M
- Total liabilities
- $43.2M
- Current liabilities
- $29.5M
- Shareholders’ equity
- $51.0M
Cash flow
- Operating cash flow
- $12.5M
- Investing cash flow
- $7.9M
- Financing cash flow
- -$9.6M
- Net cash flow
- $10.9M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $63.9M
- P/E ratio
- 14.3
- EPS (diluted)
- $0.03
- Shares outstanding
- 148.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 31, 2007
Xtant Medical Holdings, Inc. (XTNT) Stock Price
- Profitable — net income of $5.0M in FY2025.
- Revenue grew 142% from FY2021 to FY2025.
- Gross margin of 62.9%, net margin 3.7%.
- Trading 53% below its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 14.3.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Xtant Medical Holdings, Inc..
Write a review
News about Xtant Medical Holdings, Inc.
News & sentiment via Polygon.io
Xtant Medical Holdings, Inc.: frequently asked questions
Is Xtant Medical Holdings, Inc. an American company?
Xtant Medical Holdings, Inc. is a US-based company headquartered in Belgrade, Montana, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Xtant Medical Holdings, Inc. headquartered?
Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana, United States.
Is Xtant Medical Holdings, Inc. publicly traded?
Yes — Xtant Medical Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol XTNT on the NYSE.
What does Xtant Medical Holdings, Inc. do?
Xtant Medical Holdings, Inc. is an American Medical Devices company in the Health & Beauty sector.
When was Xtant Medical Holdings, Inc. founded?
Xtant Medical Holdings, Inc. was founded in 2006.
